BioCurex, Inc.(fka BOCX)

[opportunityknocking]

I would say that since the IPO a solid majority of investors (other than the churning to create the illusion of liquidity) realize the potential and are patient, because as Mata stated, "there's no drama concerning veterinary use for recaf. the company is going to license veterinary use. the only difference between recaf for humans and animals is the blood being tested and the resulting statistical modeling.

they need blood samples and this is rather an ingenious and cheap way to validate the science in order to license it.
bocxfans. look for the next license agreement and wait for inverness.

the science has been perfected and it works."